Abstract
123I-β-CIT is a radioactive ligand for single-photon emission computed tomography (SPECT) imaging of the pre-synaptic (transporter) re-uptake sites for dopamine (DAT) and serotonin (5HTT), and it is widely used to visualize monoamine turnover. Since 123I-β-CIT uptake occurs at 5HTT and DAT sites in conjunction with the presence of freely soluble 123I-β-CIT in brain tissue, adequate separation of these three components is necessary. However, only partial separation is possible with current methods. Two main strategies have previously been used for 123I-β-CIT component separation, based on the following considerations: (1) the faster uptake rate for 5HTT compared with DAT enables temporal separation by performing 5HTT imaging at 1–2 h and DAT imaging at 20–24 h; (2) blocking the 5HTT re-uptake with citalopram renders 123I-β-CIT imaging DAT (non-5HTT) specific. In a new analytical model, we combined these two approaches with methods to isolate the passively dissolved 123I-β-CIT in brain tissue from the monoamine transporter uptake, and to correct the 5HTT and DAT values for concomitant uptake. The new analytical model was used to study brain 5HTT and DAT in 23 normal subjects, with the aim of clarifying the effect of age and sex. A significant correlation between 5HTT and DAT values was found only in the thalamus, indicating successful component separation. Negative correlations between age and DAT were found for basal ganglia, thalami, brain stem and temporal lobes, but not for the frontal, parietal or occipital regions. No correlation with age was found for 5HTT. We found no sex difference for 5HTT or DAT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brucke T, Kornhuber J, Angelberger P, Asenbaum S, Fassine H, Podreka I. SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 1993; 94:137–146.
Kuikka JT, Tiihonen J, Bergstrom KA, Karhu J, Hartikainen P, Viinamaki H, Lansimies E,Lehtonen J, Hakola P. Imaging of serotonin and dopamine transporters in the living human brain. Eur J Nucl Med 1995; 22:346–350.
Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deeke L, Podreka I, Brucke T. β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human in vivo. J Neural Transm Gen Sect 1995; 100:247–256.
Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T. Imaging serotonin and dopamine transporters with123I-β-CIT SPECT: Binding kinetics and effects of normal aging. J Nucl Med 2000; 41:36–44.
van Dyck C, Seibyl J, Malison R, Laurelle M, Wallace E, Zoghbi S, Zea-Ponce Y, Baldwin R, Charney D, Hoffer P. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CIT SPECT. J Nucl Med 1995; 36:1175–1181.
Kuikka J, Tammela L, Bergström K, Karhunen L, Uusitupa M, Tiihonen J. Effects of ageing on serotonin transporters in healthy females. Eur J Nucl Med 2001; 28–911–913.
Bauman P, Larsen F. The pharmacokinetics of citalopram. Contemp Pharmacother 1995; 287–295.
Kretchmann H, Weirinch W. Neuroanatomy and cranial computed tomography. Stuttgart: Thieme, 1996.
Fujita M, Takatoku K, Matoba Y, Nishiura M, Kobayashi K, Inoue O, Nishimura T. Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters. Eur J Nucl Med 1996; 23:431–436.
Brucke T, Kornhuber J, Angelberger P, Asenbaum S, Fassine H, Podreka I. SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 1993; 94:137–146.
Farde L, Halldin C, Muller L, Suhara T, Karlsson P, Hall H. PET study of [11C]beta-CIT binding to monoamine transporters in monkey and human brain. Synapse 1994; 16:93–103.
Telang F, Volkow N, Levy A, Logan J, Fowler J, Felder C, Wong C, Wang G. Distribution of tracer levels of cocaine in the human brain as assessed with averaged [11C]cocaine images. Synapse 1999; 31:290–296.
van Dyck C, Seibyl J, Malison R, Laurelle M, Zoghbi S, Baldwin R, Innis R. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatr 2002; 10:36–43.
Kuikka J, Akerman K, Hiltunen J, Bergstrom K, Rasanen P, Vanninen E, Halldin C, Tiihonen J. Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomography. Eur J Nucl Med 1997; 24:483–487.
Stephenson C, Bigliani V, Jones H, Mulligan R, Acton P, Visvikis D, Ell P, Kerwin R, Pilowsky L. Striatal and extra-striatal D2/D3 dopamine receptor occupancy by quetiapine in vivo. [123I]-epidepride single photon emission tomography (SPET) study. Br J Psychiatry 2000; 177:408–415.
Kauppinen T, Bergström K, Heikman P, Hiltunen J, Ahonen A. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results. Eur J Nucl Med Mol Imaging 2003; 30:132–136.
Acknowledgements
This study was supported by grants from the Swedish Medical Research Council No 00084 and No 14548-01A, the Segerfalk, E & H Sjöbring, and OM Persson Foundations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ryding, E., Lindström, M., Brådvik, B. et al. A new model for separation between brain dopamine and serotonin transporters in 123I-β-CIT SPECT measurements: normal values and sex and age dependence. Eur J Nucl Med Mol Imaging 31, 1114–1118 (2004). https://doi.org/10.1007/s00259-004-1489-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-004-1489-x